The relationship between Bcl2, Bax and p53: Consequences for cell cycle progression and cell death

Molecular Human Reproduction

Volumn 4, Issue 12, 1998, Pages 1099-1109

  Basu, A ^a   Haldar, S ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Apoptosis; Bax; Bcl2; Cell cycle; p53

Indexed keywords

APOPTOSIS; ARTICLE; CELL CYCLE; CELL DEATH; CELL DIVISION; CELL LOSS; CELL PROLIFERATION; DNA DAMAGE; DNA REPLICATION; GENOME; HUMAN; HUMAN CELL; ONCOGENE; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS REGULATION; TRANSCRIPTION REGULATION; ANIMAL; BREAST; CHEMISTRY; FEMALE; MALE; METABOLISM; OVARY; PHOSPHORYLATION; PHYSIOLOGY; PROSTATE; REVIEW; STRUCTURE ACTIVITY RELATION; TESTIS; UTERUS;

BAX PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

ANIMALS; BCL-2-ASSOCIATED X PROTEIN; BREAST; CELL CYCLE; CELL DEATH; FEMALE; HUMANS; MALE; OVARY; PHOSPHORYLATION; PROSTATE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; STRUCTURE-ACTIVITY RELATIONSHIP; TESTIS; TUMOR SUPPRESSOR PROTEIN P53; UTERUS;

EID: 0031593748     PISSN: 13609947     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (127)

1. Armstrong, R.C., Aja, T., Xiang, J. et al (1996) Fas-induced activation of the cell death-related protease CPP32 is inhibited by Bcl-2 and by ICE family protease inhibitors. J. Biol. Chem., 271, 16850-16855.
2. Baffy, G., Miyashita, T., Williamson, J.R. and Reed, J.C. (1993) Apoptosis induced by withdrawal of interleukin-3 (IL-3) from an IL-3 dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced Bcl2 oncoprotein production. J. Biol. Chem , 268, 6511-6519.
3. Bakshi, A., Jensen, J P., Goldman, P. et al. (1985) Cloning the chromosomal break-point of the t(14,18) human lymphomas, clustering around JH on chromosome 14 and near a transcriptional unit 18. Cell, 41, 889-906.
4. Basu, A. and Haldar, S. (1996) Apoptosis, antiapoptosis and Bcl2. EOS J. Immunol. Immunopharmacol., 16, 41-47
5. Basu, A. and Haldar, S. (1998) Microtubule-damaging drugs triggered Bcl2 phosphorylation-requirement of phosphorylation on both serine-70 and serine-87 residues of Bcl2 protein. Int. J Oncol , 13, 659-664.
6. Blagosklonny, M.V., Schuttle, T., Nguyen, P. et al. (1996) Taxol induced apoptosis and phosphorylation of bcl2 protein involves c-Raf signal transduction pathway. Cancer Res., 56, 1851-1854.
7. Blagosklonny, M.V., Giannakakou, P., El-Deiry, W.S. et al. (1997) Raf-I/bcl-2 phosphorylation, a step from microtubule damage to cell death. Cancer Res , 57, 130-135.
8. Boe, R., Gjertsen, B.T., Vintermyr, O.K. et al (1991) The protein phosphatase inhibitor okadaic acid induces morphological changes typical of apoptosis in mammalian cells. Exp. Cell Res., 195, 237-246.
9. Boersma, A.W., Nooter, K., Burger, H. et al. (1997) Bax upregulation is an early event in human testicular germ-cell line NT2, as quantitated by flow cytometry. Cytometry, 27, 275-282.
10. Boise, L.H., Gonzalez-Garcia, M., Postema, C.E. et al. (1993) bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell, 74, 597-608.
11. Borner, C., Martinou, I., Mattmann, M. et al. (1994) The protein bcl-2 alpha does not require membrane attachment, but two Conserved domains to suppress apoptosis. J. Cell Biol., 126, 1059-1068.
12. Boulakia, C.A., Chen, G., Ng, F.W.H. et al. (1996) Bcl-2 and adenovirus E1B 19 kDa protein prevent E1A-induced processing of CPP32 and cleavage of poly(ADP-ribose) polymerase. Oncogene, 12, 529-535.
13. Caelles, C., Heimberg, A. and Karin, M. (1994) p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature, 370, 220-224
14. Canman, C., Gilmer, T M., Coutts, S.B. and Kastan, M.B. (1995) Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev., 9, 600-611
15. L and Bcl-2. EMBO J., 16, 968-977.
16. Chao, D.T. and Korsmeyer, S.J. (1998) BCL2 family: regulators of cell death. Annu. Rev. Immunol., 16, 395-419.
17. Chittenden,T., Flemington, C., Houghton, R.G. et al. (1995) A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. EMBO J., 14, 5589-5596.
18. Chittenden,T., Harrington, E.A., O'Connor, R. et al. (1995) Induction of apoptosis by the Bcl-2 homologue Bak. Nature, 374, 733-736.
19. Chinnaiyan, A.M., Orth, K., O'Rourke, K. et al. (1996) Molecular ordering of the cell death pathway. J. Biol. Chem., 271, 4573-4576.
20. Chresta, C.M., Masters, J R. and Hickman, J.A. (1996) Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax:Bcl-2 ratio. Cancer Res., 56, 1834-1841.
21. Clarke, A.R., Purdie, C.A., Harrison, R G. et al. (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature, 362, 849-852.
22. Clarke, A.R., Gledhill, S., Hooper, M L et al. (1994) p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation. Oncogene, 9, 1767-1773.
23. Cleary, M.L., Smith, S.D.and Sklar, J. (1986) Cloning and structural analysis of cDNAs for bcl2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14,18) translocation. Cell, 47, 19-28.
24. Colombel, M., Symmans, F., Gil, S. et al. (1993) Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory prostate cancers. Am. J. Pathol., 143, 390-400.
25. Datta, S.R., Dudek, H., Tao, X. et al. (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell, 91, 231-241.
26. Diebold, J , Baretton, G., Felchner, M. et al. (1996) Bcl-2 expression. p53 accumulation and apoptosis in ovarian carcinomas. Am. J. Clin. Pathol., 105, 341-349.
27. Donehower, L.A., Harvey, M., Slagle, B.L. et al. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature, 356, 215-221.
28. D'Sa-Eipper, C., Subramanian, T. and Chinnadurai, G. (1996) Bfl-1, a bcl-2 homologue, suppresses p53-induced apoptosis and exhibits potent cooperative transforming activity. Cancer Res., 56, 3879-3882.
29. El-Deity, W.S., Tokino, T., Velculescu, V.E. et al. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell, 75, 817-825.
30. Elangovan, B and Chinnadurai, G. (1997) Functional dissection of the proapoptotic protein Bik, heterodimenzation with anti-apoptosis proteins is insufficient for induction of cell death. J. Biol. Chem , 272, 24494-24498.
31. Elipoulos, A.G., Kerr, D.J., Herod, J. et al. (1995) The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2. Oncogens, 11, 1217-1228.
32. Farrow, S.N., White, J.H.M., Martinou, I. et al. (1995) Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature, 374, 731-733.
33. Gibson, L., Holmgreen, S.P., Huang, D.C. et al. (1996) bcl-w, a novel member of the bcl-2 family, promotes cell survival. Oncogene, 13, 665-675.
34. Guillouf, C., Rosselli, F., Krishnaraju, K. et al. (1995) p53 involvement in control of G2 exit of the cell cycle: role in DNA damage-induced apoptosis. Oncogene, 10, 2263-2270.
35. Haldar, S., Jena, N. and Croce, C.M. (1995) Inactivation of bcl2 by phosphorylation. Proc. Natl Acad. Sci. USA, 92, 4507-4511.
36. Haldar, S., Chintapalli, J. and Croce, C.M. (1996) Taxol induces Bcl2 phosphorylation and death of prostate cancer cells. Cancer Res., 56, 1253-1255.
37. Haldar, S., Basu, A. and Croce, C.M. (1997) Bcl2 is the guardian of microtubule integrity. Cancer Res., 57, 229-233.
38. Haldar, S., Basu, A. and Croce, C.M. (1998) Serine-70 is one of the critical sites for drug-induced Bcl2 phosphorylation in cancer cells. Cancer Res., 58, 1609-1615.
39. Haldar, S., Jena, N., Coss, R.W. et al. (1994a) Cellular localization of bcl2 protein and response to glucocorticoid stress. Cell Death Differentiation, 1, 109-115.
40. Haldar, S., Negrini, M., Monne, M. et al. (1994b) Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res., 54, 2095-2097.
41. Han, J., Sabbatini, P. and White, E. (1996) Induction of apoptosis by human Nbk/Bik, a BH3-containing protein that interacts with EIB 19K. Mol. Cell Biol., 16, 5857-5864.
42. Hanada, M., Aime-Sampe, C., Sato, T. and Reed, J. C. (1995) Structure-function analysis of bcl-2 protein, identification of conserved domains important for homodimrization with bcl-2 and heterodimenzation with bax. J. Biol. Chem., 270, 11962-11969.
43. Hartwell, L.H. and Kastan, M.B. (1994) Cell cycle control and cancer. Science, 266, 1821-1828.
44. Henderson, S., Huen, D., Rowe, M. et al. (1993) Epstein Barr virus coded bhrf1 protein, a viral homolog of bcl2, protects human B cells from programmed cell death. Proc. Natl. Acad. Sci. USA, 90, 8489-8493.
45. Hengartner, M.O. (1996) Programmed cell death in invertebrates. Curr. Opin. Genet. Dev., 6, 34-38.
46. Hengartner, M.O. and Horvitz, H.R (1994) C.elegans cell survival gene CED-9 encodes a functional homology of the mammalian prot-oncogene bcl2. Cell, 76, 665-676.
47. Henrickson, R., Willander, E. and Oberg, K. (1995) Expression and prognostic significance of Bcl-2 in ovanan tumors. Br. J. Cancer, 72, 1324-1329.
48. Hockenbery, D., Nunez, G., Milliman, C. et al. (1990) Bcl2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature, 348, 334-336.
49. Hockenbery, D.M., Oltvai, Z. N., Yin, X-M. et al. (1993) Bcl2 functions in an antioxidant pathway to prevent apoptosis. Cell, 75, 241-251.
50. Hsu, S.Y., Kaipia, A., McGee, E. et al. (1997) Bok is a pro-apoptotic protein with restricted expression in reproductive tissues and heterodimerizes with selective anti-apoptotic Bcl-2 family members. Proc. Natl. Acad. Sci. USA, 94, 12401-12406.
51. Hunter, J.J. and Parslow, T.G. (1996) A peptide sequence from Bax that converts Bcl-2 into an activator of apoptosis. J. Biol Chem., 271, 8521-8524.
52. Inohara, N., Ding, L., Chen, S. and Nunez, G. (1997) harakini, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bcl-2 and Bcl-X(L). EMBO J.. 16, 1686-1694.
53. Jacobson, M.D., Burne, J.F., King, M P. et al. (1993) Bcl2 blocks apoptosis in cells lacking mitochondrial DNA. Nature, 361, 365-369.
54. Jost, C.A., Marin, M.C. and Kaelin, W.G. Jr (1997) p73 is a human p53-related protein that can induce apoptosis. Nature, 389, 191-194.
55. Kane, D.J., Sarafin, T.A , Auton, S. et al. (1993) Bcl-2 inhibition of neural cell death, decreased generation of reactive oxygen species. Science, 262, 1274-1277.
56. Kaghdad, M., Bonnet, H., Yang, A. et al. (1997) Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell, 90, 809-819.
57. Kiefer, M.C., Brauer, M.J., Powers, V.C. et al. (1995) Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature, 374, 736-739.
58. Kitada, S., Krajewski, S., Miyashita, T. et al. (1996) Gamma-radiation induces upregulation of Bax protein and apoptosis in radiosensitive cells in vivo. Oncogene, 12, 187-192.
59. Kluck, R.M., Bossy-Wetzel, E., Green, D R. and Newmeyer, D.D. (1997) The release of cytochrome c from mitochondria, a primary site for Bcl-2 regulation of apoptosis. Science, 275, 1132-1136.
60. Knudson, C.M. and Korsmeyer, S.J. (1997) Bcl-2 and Bax function independently to regulate cell death. Nature Genet., 16, 358-363.
61. Knudson, C.M., Tung, K.S.K., Tourtellotte, W.O. et al. (1995) Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science, 270, 96-99
62. Kozopas, K.M., Yang, T., Buchan, H.L. et al. (1993) Mcl-1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to bcl-2. Proc. Natl. Acad. Sci. USA, 90, 3516-3520.
63. Kroemer, G. (1997) The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Med., 3, 614-620.
64. Krajewska, M., Krajewski, S., Epstein, J.I. et al. (1996) Immunohistochemical analysis of bcl-2, bax, bcl-x and mcl-1 expression in prostate cancers. Am. J. Pathol , 148, 1567-1576.
65. Krajewski, S., Tanaka, S. and Takayama, S. (1993) Investigations of the subcellular distribution of the bcl-2 oncoprotein, residence in the nuclear envelope, endoplastic reticulum and outer mitochondrial membranes. Cancer Res., 53, 4701-4714.
66. Krajewski, S., Boudrug, S., Gascoyne, R. et al. (1994) Immunohistochemical analysis of Mcl-1 and Bcl-2 proteins in normal and neoplastic lymph nodes. Am. J. Pathol., 145, 515-525.
67. Krajewski, S., Blomqvist, C., Franssila, K. et al. (1995) Reduced expression of proapoptotic gene Bax is associated with poor response and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res., 55, 4471-4478.
68. 2+ fluxes. Proc. Natl. Acad. Sci. USA, 91, 6569-6573.
69. Lea, R.G., al-Sharekh, N., Tulppala, M. and Critchley, H O. (1997) The immunolocalization of Bcl-2 at the maternal-fetal interface in healthy and failing pregnancies Hum. Reprod., 12, 153-158.
70. Leek, R D., Kaklamanis, L., Pezella, F. et al. (1994) Bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumors and in situ cancer. Br. J. Cancer, 69, 135-139.
71. Levine, A.J. (1997) p53. the cellular gatekeeper for growth and division. Cell, 88, 323-331.
72. Lin, E.Y., Orlofsky, A., Berger, M.S. and Prystowsky, M.B. (1993) Characterization of A1, a novel hemopoietic-specific early response gene with sequence similarity to bcl-2. J. Immunol , 151, 1979-1988.
73. Liu, X, Kim, C.N., Yang, J. et al. (1996) Induction of apoptotic program in cell-free extract, requirement for dATP and cytochrome C. Cell, 86, 147-157
74. Lowe, S.W., Ruley, H.E., Jacks, T. and Housman, D.E. (1993) p53 dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74, 957-967.
75. Lu, Q-L., Abel, P , Foster, C.S. and Lalani, E-N. (1996) Bcl2: role in epithelial differentiation and oncogenesis Hum. Pathol., 27, 102-110
76. Marvel, J., Perkins, G.R., Lopez Rivas, A. and Collins, M.K. (1994) Growth factor starvation of bcl-2 overexpressing murine bone marrow cells induced refractoriness to IL-3 stimulation of proliferation. Oncogene, 9, 1117-1122.
77. Marx, D., Binder, C., Meden, H et al. (1997) Differential expression of Bax and Bcl2 in ovarian cancer. Anticancer Res., 17, 2233-2240.
78. McCurrach, M.E., Connor, T.M., Knudson, C.M. et al (1997) Bax deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc. Natl. Acad. Sci. USA, 94, 2345-2349.
79. McLaren, J., Prentice, A., Chamock-Jones, D.S. et al. (1997) Immunolocalization of the apoptosis regulating proteins Bcl-2 and Bax in human endometrium and isolated peritoneal fluid macrophages in endometriosis. Hum. Reprod , 12, 146-152.
80. Meikrantz, W. and Schlegel, R. (1995) Apoptosis and the cell cycle. J. Cell. Biochem , 58, 160-174.
81. Merritt, A.J., Potten, C.S., Kemp, C.J. et al. (1994) The role of p53 in spontaneous and radiation-induced apoptosis. Cancer Res., 54, 614-617.
82. Merritt, A. J., Allen, T.D., Potten, C.S. and Hickman, J.A. (1997) Apoptosis in small intestinal epithelial from p53-null mice, evidence for a delayed, p53-independent G2/M associated cell death after gamma-irradiation. Oncogene, 14, 2759-2766.
83. L and loss of P53 can cooperate to overcome in cell cycle checkpoint induced by mitotic spindle damage. Genes Dev., 10, 2621-2631.
84. Minn, A.J., Velez, P., Schendel, S.L. et al. (1997) Bcl-xL forms an ion channel in synthetic lipid membranes. Nature, 385, 353-357.
85. Miura, M., Zhu, H., Rotello, R. et al. (1993) Induction of apoptosis in fibroblasts by IL-1β converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell, 75, 653-660.
86. Miyashita, T., Krajewski, S., Krajewska, M. et al. (1994a) Tumor suppressor p53 is a regulator of bcl-2 and Bax in gene expression in vitro and in vivo. Oncogene, 9, 1799-1805.
87. Miyashita, T., Harigal, M., Hanada, M. and Reed J.C. (1994b) Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res., 54, 3131-3135.
88. Miyashita, T. and Reed, J.C. (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80, 293-299.
89. Moore, J.S., Friedman, D.F., Silberstein, L.E. et al. (1995) Clinical heterogenity reflects biologic diversity in chronic lymphocytic leukemia. Crit. Rev. Oncol./Hematol., 20, 141-164.
90. L, an inhibitor of programmed cell death. Nature, 381, 335-341.
91. Neilan, J.G., Lu, Z., Afonso, C.L. et al. (1993) An African swine fever virus gene with similarity to the proto-oncogene Bcl-2 and the Epstein-Barr virus gene BHRF1. J. Virol., 67, 4391-4394.
92. Olie, R.A., Boersma, A.W., Dekker, M.C. et al. (1996) Apoptosis of human seminoma cells upon disruption of their microenvironment. Br. J Cancer, 73, 1031-1036.
93. Oltvai, Z.N., Milliman, C.L. and Korsmeyer, S.J. (1993) Bcl2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 75, 609-619.
94. Ferez, G.I., Knudson, C.M., Leykin, L. et al (1997) Apoptosis-associated signaling pathways are required for chemotherapy-mediated female germ cell destruction. Nature Med., 3, 1228-1232.
95. Peso, L D., Gonzalez-Garcia, M., Page, C. et al. (1997) Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science, 278, 687-689.
96. Ratts V.S., Flaws, J.A., Kolp, R et al. (1995) Ablation of bcl-2 gene expression decreases the number of oocytes and primordial follicles established in the post-natal female mouse gonad. Endocrinology, 136, 3665-3669.
97. Reed, J.C. (1997) Double identity for proteins of the Bcl2 family. Nature, 387, 773-776.
98. Sato, T., Hanada, M., Bodrug, S. et al. (1994) Interactions among members of the bcl-2 protein family analyzed with a yeast two-hybrid system. Proc Natl. Acad. Sci. USA, 91, 9238-9242.
99. Schendel, S.L., Xie, Z., Montal, M.O. et al. (1997) Channel formation by antiapoptotic protein Bcl-2. Proc. Natl. Acad. Sci. USA, 94, 5113-5118.
100. Selvakumaran, M., Lin, H-K, Miyashita, T. et al. (1994) Immediate early up-regulation of bax expression by p53 but not TGFβ1, a paradigm for distinct apoptotic pathways. Oncogene, 9, 1791-1798.
101. Srivastava, R.K , Srivastava, A.R , Korsmeyer, S.J. et al. (1998) Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase. Mol. Cell. Biol., 18, 3509-3517.
102. Symonds, H., Krail, L., Remington, L et al. (1994) p53-dependent apoptosis in vivo, impact of p53 inactivation on tumorigenesis. Cold Spring Harbor Symp. Quant Biol., 59, 247-257.
103. Takayama, S., Sato, T., Krajewski, S. et al. (1995) Cloning and functional analysis of BAG-1, a novel Bcl-2 binding protein with anti-cell death activity. Cell, 80, 279-284.
104. Taniguchi, J., Moriyama, N., Kurimoto, S. et al. (1996) Histochemical deletion of intranuclear DNA fragmentation and its relation to the expression of bcl-2 oncoprotein in human prostatic cancer. Br. J. Cancer, 77, 719-723
105. Teixeira, C., Reed, J.C. and Pratt, M.A. (1995) Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 protooncogene expression in human breast cancer cells. Cancer Res., 55, 3902-3907.
106. Thomas, A., Rouby, S. E., Reed, J.C. et al. (1996) Drug-induced apoptosis in B-cell chronic lymphocytic leukemia, relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance. Oncogene, 12, 1055-1062.
107. Tsujimoio, Y., Finger, L.R., Nowell, P.C. and Croce, CM. (1984) Cloning of the chromosome breakpoint of neoplastic B cells with the t(14,18) chromosome translocation. Science, 226, 1097-1099.
108. Tsujimoto, Y., Cossman, J., Jaffe, E. and Croce, C.M. (1985) Involvement of the Bcl2 gene in follicular lymphoma. Science, 228, 1440-1443.
109. Uhlmann, E.J., D'Sa-Eipper, C., Subramanian, T. et al. (1996) Detection of a nonconserved region of Bcl-2 confers a novel gain of function, suppression of apoptosis wilh concomitant cell proliferation. Cancer Res., 56, 2506-2509.
110. Vaux, D. L., Cory, S. and Adams, J.M. (1988) Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize preB cells. Nature, 335, 440-442.
111. Wang, H.-G , Miyashita, T., Takayama, S. et al. (1994) Apoptosis regulation by interaction of bcl-2 protein and Raf-1 kinase. Oncogene, 9, 2751-27.
112. Wang, H.G., Millan, J.A., Cox, A.D. et al. (1995) R-ras promotes apoptosis caused by growth factor deprivation via a Bcl-2 suppressible mechanism. J. Cell Biol., 129, 1103-1114.
113. Wang, H.G , Rapp, U.R. and Reed, J.C. (1996) Bcl-2 targets the protein kinase Raf-1 to Mitochondria. Cell, 87, 629-638.
114. Wang, K., Yin, X.M.. Chao, D.T. et al. (1996) BID: a novel BH3 domainonly death agonist. Genes Dev., 10, 2859-2869.
115. White, E. (1996) Life, death and pursuit of apoptosis. Genes Dev., 10, 1-15.
116. White, E., Sabbatini, P., Debbas, M. et al. (1992) The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor alpha. Mol. Cell. Biol., 12, 2570-2580.
117. Yang, E. and Korsmeyer, S.J. (1996) Molecular thanaptosis, a discourse on the BCL2 Family and cell death. Blood, 88, 386-401.
118. L and Bcl-2, displaces bax and promotes cell death. Cell, 80, 285-291.
119. Yang, J., Liu, X, Bhalla, K. et al. (1997) Prevention of apoptosis by Bcl-2, release of cytochrome c from mitochondria. Science, 275, 1129-1132.
120. Yin, X.M., Oltvai, Z.N. and Korsmeyer, S.J. (1994) BH1 and BH2 domains of Bcl2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature, 369, 321-323.
121. Yuan, J. (1997) Transducing signals of life and death. Curr Opin. Cell Biol., 9, 241-251.
122. Yuan, J., Shaham, S., Ledoux, S. et al. (1993) The C elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell, 75, 641-652.
123. Zha, H., Aime-Sempe, C., Sato, T. and Reed, J.C. (1996) Pro-apoptotic protein Bax heterodimrizes with Bel-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2. J. Biol. Chem., 271, 7440-7444.
124. Zha, J., Hanada, H., Yang, E. et al. (1996) Senne phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not Bcl-xL. Cell, 87, 619-628.
125. Zhan, Q., Carrier, F. and Fornace, A.J. (1993) Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Mol. Cell. Biol., 13, 4242-4250.
126. Zhan, Q., Fan, S., Bae, I. et al. (1994) The Gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth. Oncogene, 9, 3743-3751.
127. Ziegler, A., Jonason, A.S., Leffell, D J. et al. (1994) Sunburn and p53 in the onset of skin cancer. Nature, 372, 773-776.